Pharmaceuticals and Life Sciences
Architecture documentation for clinical trial systems, drug development pipelines, FDA 21 CFR Part 11 compliance, laboratory information systems, and GxP validation.
Pharmaceutical and life sciences organisations develop, manufacture, and distribute products under rigorous regulatory oversight from the FDA, EMA, and global health authorities. Technology systems supporting clinical trials, drug development, manufacturing, and pharmacovigilance must comply with 21 CFR Part 11, GxP requirements, and data integrity standards (ALCOA+). Every system that touches regulated data needs documented architecture, risk assessments, and traceable change history - requirements that most documentation tools were not designed to satisfy.
Key Challenges in Life Sciences Technology
How NeoArc Addresses Life Sciences Needs
Use Cases by Subsector
Requirements-to-Features Mapping
Discover how NeoArc Studio addresses architecture documentation needs across 17 industries including financial services, healthcare, government, aerospace, manufacturing, energy, and more.
Document healthcare architecture with data protection controls, PHI handling procedures, and self-hosted deployment for HIPAA compliance.